CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sientra Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sientra Inc
3333 Michaelson Dr, Suite 650
Phone: (805) 562-3500p:805 562-3500 IRVINE, CA  92612  United States Ticker: SIENQSIENQ

Filed for Bankruptcy on 2/12/2024
Case #24-10245, filed in the U.S. Bankruptcy Court for the District of Delaware

Business Summary
Sientra, Inc. is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYesYes-Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board CarolineVan Hove 42 11/9/2020 1/1/2020
President, Chief Executive Officer, Director RonaldMenezes 60 11/10/2020 11/10/2020
Chief Financial Officer, Senior Vice President, Treasurer AndrewSchmidt 61 7/12/2021 7/12/2021
6 additional Officers and Directors records available in full report.

Business Names
Business Name
bioCorneum®
miraDry Holdings, Inc.
miraDry International Sweden AB
9 additional Business Names available in full report.

General Information
Number of Employees: 304 (As of 12/31/2022)
Outstanding Shares: 11,957,712 (As of 11/9/2023)
Shareholders: 216
Stock Exchange: OTC
Federal Tax Id: 205551000
Fax Number: (805) 562-8401
Email Address: info@sientra.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 29, 2024